Article
Novel single-cell technologies in acute myeloid leukemia research.
Translational research : the journal of laboratory and clinical medicine - 1 Nov 2017
Gupta Soumyasri Das, Sachs Zohar
Abstract excerpt
Acute myeloid leukemia (AML) is a lethal malignancy because patients who initially respond to chemotherapy eventually relapse with treatment refractory disease. Relapse is caused by leukemia stem cells (LSCs) that reestablish the disease through self-renewal. Self-renewal is the ability of a stem cell to produce copies of itself and give rise to progeny cells. Therefore, therapeutic strategies eradicating LSCs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
